This is a preview of subscription content, log in via an institution to check access.
Notes
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients With Renal Impairment and Chronic Hepatitis C Virus Genotype 1-6 Infection
2017 US dollars
Reference
Eckman MH, et al. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis. Annals of Internal Medicine : 10 Jul 2018. Available from: URL: http://doi.org/10.7326/M17-3088
Rights and permissions
About this article
Cite this article
HCV-infected renal transplant cost effective in patients with HCV. PharmacoEcon Outcomes News 808, 18 (2018). https://doi.org/10.1007/s40274-018-5133-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5133-6